Innovation Pharmaceuticals Inc.
Innovation Pharmaceuticals Inc. (IPIX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IPIX · as of Sep 30, 2024
Ownership Breakdown
2
Institutional Holders
▲ 1 vs Q2
$13
Total Inst. Value
▼ $54 vs Q2
518.35M
Shares Outstanding
freeFloat 99.18%
66,894
13F Shares Held
▲ 11,000 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IPIX largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 2 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ABLE WEALTH MANAGEMENT LLC pharmaceutical preparations | 55.9K | 1.08% | 1.08% | $11,000 | Nov 1, 2024 | — held |
KINGFISHER CAPITAL LLC pharmaceutical preparations | 11.0K | 0.21% | 0.21% | $2,000 | Nov 14, 2024 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+1
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IPIX insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$11M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
EHRLICH LEO CEO and Chairman | Dec 30, 2022 | J-Other | 11,307,527 | — | — | 4.33M | Form 4 ↗ |
Harness Jane A. Vice President | Oct 10, 2021 | Award | 500,000 | $0.24 | $120.0K | 500.0K | Form 4 ↗ |
Harness Jane A. Vice President | Sep 11, 2020 | Award | 58,394 | — | — | 244.4K | Form 4 ↗ |
Harness Jane A. Vice President | Sep 1, 2019 | Award | 58,394 | — | — | 207.6K | Form 4 ↗ |
Harness Jane A. Vice President | Sep 11, 2020 | Tax Withhold | 21,606 | — | — | 186.0K | Form 4 ↗ |
Harness Jane A. Vice President | Sep 1, 2019 | Award | 172,987 | $0.13 | $22.5K | 173.0K | Form 4 ↗ |
Harness Jane A. Vice President | Sep 11, 2020 | Award | 172,987 | $0.22 | $38.1K | 173.0K | Form 4 ↗ |
Harness Jane A. Vice President | Sep 1, 2017 | Tax Withhold | 1,000 | — | — | 149.2K | Form 4 ↗ |
Schechter Barry A director | Oct 10, 2021 | Award | 1,000,000 | $0.24 | $240.0K | 1.00M | Form 4 ↗ |
Schechter Barry A director | Feb 23, 2020 | Award | 500,000 | — | — | 750.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Innovation Pharmaceuticals Inc. (IPIX) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 0.82%, while retail and public investors account for the remaining 99.17%.
The largest institutional shareholder of Innovation Pharmaceuticals Inc. is ABLE WEALTH MANAGEMENT LLC, holding approximately 55,894 shares — equal to 1.08% of outstanding shares — as of September 30, 2024.
A total of 2 institutional investors currently hold IPIX stock, with a combined institutional value of approximately $13 as of the most recent 13F filing period.
Frequently asked questions
IPIX ownershipInnovation Pharmaceuticals Inc. (IPIX) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is ABLE WEALTH MANAGEMENT LLC with a 1.08% stake. Company insiders hold 0.82%. Data sourced from SEC Form 13F as of September 30, 2024.